The STEP 1 trial showed average weight loss of 14.9% over 68 weeks
Detailed conversion scenarios The following are detailed conversion scenarios of GLP-1 medications: Switching from liraglutide (Victoza/Saxenda) to semaglutide (Ozempic/Wegovy) Liraglutide is a daily injection, while semaglutide is administered once weekly
Examples of effective anchors: Morning injectors: "After I brush my teeth and before I make coffee" or "Right after my alarm goes off, before I check my phone." Evening injectors: "Right after I brush my teeth for bed" or "Immediately after I put the kids to sleep." The key is specificity
The results of the phase 3 clinical trial of retatrutide are eagerly awaited, as it is expected that over a longer time period its efficacy in weight loss will be even greater
Remedy Meds and Mochi represent two distinct telehealth models for GLP-1 medication access
Konturek SJ, Bilski J, Pawlik W, Tasler J, Domschke W